Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NR1H3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
NR1H3 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
NR1H4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
NR1H4 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
THRB Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
THRB target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
INSR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
INSR target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
IGF1R Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
IGF1R target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
GHR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
GHR target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
LEPR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
LEPR target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
MC4R Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MC4R target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
GCGR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
GCGR target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
GIPR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
GIPR target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
GLP1R Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
GLP1R target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
SLC5A2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
SLC5A2 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.